Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-06 2:36 pm Sale |
2022-12-30 | 13G | Zymeworks Inc. ZYME |
WELLINGTON MANAGEMENT CO LLP | 0 0.000% |
-2,856,986 (Position Closed) |
Filing History |
| 2023-02-06 2:36 pm Sale |
2022-12-30 | 13G | Chubb Limited CB |
WELLINGTON MANAGEMENT CO LLP | 19,714,509 4.750% |
-7,931,290 (-28.69%) |
Filing History |
| 2023-02-06 2:36 pm Purchase |
2022-12-30 | 13G | ANDINA BOTTLING CO INC | WELLINGTON MANAGEMENT CO LLP | 32,481,614 6.860% |
32,481,614 (New Position) |
Filing History |
| 2023-02-06 2:36 pm Sale |
2022-12-30 | 13G | Abcam plc ABCM |
WELLINGTON MANAGEMENT CO LLP | 15,066,586 6.570% |
-1,934,468 (-11.38%) |
Filing |
| 2023-02-06 2:36 pm Sale |
2022-12-30 | 13G | Luxfer Holdings PLC LXFR |
WELLINGTON MANAGEMENT CO LLP | 2,316,296 8.510% |
-474,125 (-16.99%) |
Filing History |
| 2023-02-06 2:36 pm Purchase |
2022-12-30 | 13G | Verona Pharma plc VRNA |
WELLINGTON MANAGEMENT CO LLP | 26,770,960 4.430% |
26,770,960 (New Position) |
Filing History |
| 2023-02-06 2:36 pm Sale |
2022-12-30 | 13G | Alkermes plc ALKS |
WELLINGTON MANAGEMENT CO LLP | 6,044,378 3.680% |
-5,763,844 (-48.81%) |
Filing History |
| 2023-02-06 2:36 pm Purchase |
2022-12-30 | 13G | Johnson Controls International plc JCI |
WELLINGTON MANAGEMENT CO LLP | 55,028,882 8.010% |
7,163,428 (+14.97%) |
Filing History |
| 2023-02-06 2:36 pm Sale |
2022-12-30 | 13G | ICON Public Limited Company ICLR |
WELLINGTON MANAGEMENT CO LLP | 2,782,561 3.410% |
-2,372,036 (-46.02%) |
Filing History |
| 2023-01-10 09:23 am Purchase |
2022-12-30 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
WELLINGTON MANAGEMENT CO LLP | 7,983,442 11.720% |
6,384,676 (+399.35%) |
Filing History |
| 2022-12-09 1:50 pm Sale |
2022-11-30 | 13G | Cardlytics, Inc. CDLX |
WELLINGTON MANAGEMENT CO LLP | 18,531 0.060% |
-1,932,876 (-99.05%) |
Filing History |
| 2022-12-09 1:50 pm Sale |
2022-11-30 | 13G | Lumentum Holdings Inc. LITE |
WELLINGTON MANAGEMENT CO LLP | 5,368,746 7.860% |
-4,474,199 (-45.46%) |
Filing History |
| 2022-12-09 1:50 pm Sale |
2022-11-30 | 13G | PGT Innovations, Inc. PGTI |
WELLINGTON MANAGEMENT CO LLP | 4,617,237 7.700% |
-3,026,578 (-39.60%) |
Filing History |
| 2022-12-09 1:50 pm Sale |
2022-11-30 | 13G | Repay Holdings Corporation RPAY |
WELLINGTON MANAGEMENT CO LLP | 7,655,075 8.390% |
-4,989,957 (-39.46%) |
Filing History |
| 2022-12-09 1:50 pm Purchase |
2022-11-30 | 13G | Revolution Medicines, Inc. RVMD |
WELLINGTON MANAGEMENT CO LLP | 8,936,469 10.060% |
4,425,574 (+98.11%) |
Filing History |
| 2022-11-10 07:56 am Purchase |
2022-10-31 | 13G | UCB S.A. | WELLINGTON MANAGEMENT CO LLP | 19,724,818 10.140% |
19,724,818 (New Position) |
Filing History |
| 2022-11-10 07:56 am Purchase |
2022-10-31 | 13G | Cinemark Holdings, Inc. CNK |
WELLINGTON MANAGEMENT CO LLP | 12,722,193 10.550% |
2,105,163 (+19.83%) |
Filing History |
| 2022-11-10 07:56 am Sale |
2022-10-31 | 13G | CommScope Holding Company, Inc. COMM |
WELLINGTON MANAGEMENT CO LLP | 6,922,582 3.330% |
-11,028,601 (-61.44%) |
Filing History |
| 2022-11-10 07:56 am Sale |
2022-10-31 | 13G | Olo Inc. OLO |
WELLINGTON MANAGEMENT CO LLP | 6,629,894 6.480% |
-995,092 (-13.05%) |
Filing History |
| 2022-11-10 07:56 am Sale |
2022-10-31 | 13G | Perella Weinberg Partners PWP |
WELLINGTON MANAGEMENT CO LLP | 4,895,512 12.010% |
-3,479,893 (-41.55%) |
Filing History |